RARE Drug Development Symposium: Working with Advocacy Groups

In a session tailored towards rare disease researchers, Benjamin Forred, Rob Long, and Vivian Fernandez discuss how advocacy groups can position themselves as a resource, and how stakeholders should engage patients in a variety of ways.